Prolonged survival of neoplastic meningitis from breast cancer with letrozole and intrathecal methotrexate: A case report

Journal of Neuro-Oncology

Volumn 101, Issue 3, 2011, Pages 509-511

  Peroukides, Stavros ^a   Onyenadum, Adimchi ^a   Starakis, Ioannis ^a   Koutras, Angelos ^a   Makatsoris, Thomas ^a   Bouboukas, George ^a   Kalofonos, Haralabos ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Breast carcinoma; Cerebrospinal fluid; Letrozole; Methotrexate; Neoplastic meningitis

Indexed keywords

CYCLOPHOSPHAMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; FLUOROURACIL; LETROZOLE; METHOTREXATE; PHENYTOIN; PREDNISOLONE; PROGESTERONE RECEPTOR; TAMOXIFEN;

ADULT; ARTICLE; ATAXIA; BREAST ADENOCARCINOMA; CANCER STAGING; CANCER SURVIVAL; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CONFUSION; CONSCIOUSNESS DISORDER; DRUG DOSE REDUCTION; DRUG FEVER; DRUG RESPONSE; DRUG WITHDRAWAL; FEMALE; HEADACHE; HUMAN; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; KARNOFSKY PERFORMANCE STATUS; LIMB WEAKNESS; LUMBAR PUNCTURE; LYMPH NODE DISSECTION; MASTECTOMY; MENINGITIS; MENTAL HEALTH; MULTIPLE CYCLE TREATMENT; NEOPLASTIC MENINGITIS; RETREATMENT; SURVIVAL TIME; WALKING DIFFICULTY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; FEMALE; HUMANS; INJECTIONS, SPINAL; MENINGITIS; METHOTREXATE; MIDDLE AGED; NITRILES; PROGNOSIS; SURVIVAL RATE; TRIAZOLES;

EID: 79952191684     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0268-8     Document Type: Article

References (11)

1. Moots P, Harrison M, Vandenberg S (1995) Prolonged survival in carcinomatous meningitis associated with breast cancer. South Med J 88:357-362
2. Boogerd W, Bent MJ, Koehler PJ et al (2004) The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomized study. Eur J Cancer 40:2726-2733 (Pubitemid 39574724)
3. Chamberlain M (2005) Neoplastic meningitis. J Clin Oncol 23:3605-3613
4. Chamberlain M (2008) Neoplastic meningitis. The Oncologist 13:967-977
5. Boogerd W, Dorresteijn LD, van Der Sande JJ, de Gast GC, Bruning PF (2000) Response of leptomeningeal metastases from breast cancer to hormonal therapy. Neurology 12:117-119 (Pubitemid 30461010)
6. Ozdogan M, Samur M, Bozcuk H et al (2003) Durable remission of leptomeningeal metastasis of breast cancer with letrozole: a case report and implications of biomarkers on treatment selection. Jpn J Clin Oncol 33:229-231 (Pubitemid 43115263)
7. Jayson G, Howell A (1996) Carcinomatous meningitis in solid tumors. Ann Oncol 7:773-786
8. Garcia-Casado Z, Guerrero-Zotano A, Llombart-Cussac A et al (2010) A polymorphism at the 30-UTR region of the aromatase gene defines a subgroup of postmenopausal breast cancer patients with poor response to neoadjuvant letrozole. BMC Cancer 10:36
9. Neville-Webbe HL, Coleman RE, Holen I (2010) Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interaction. Br J Cancer 102:1010-1017
10. Lien EA, Wester K, Lonning PE, Solheim E, Ueland PM (1991) Distribution of tamoxifen and metabolites into brain tissue and brain metastases in breast cancer patients. Br J Cancer 63:641-645
11. Madhup R, Kirti S, Bhatt MLB et al (2006) Letrozole for brain and scalp metastases from breast cancer - a case report. The Breast 15:440-442